/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | FENCFENNEC PHARMACEUTICA |
|---|---|
| Last close | $10.15 |
| Change % | +0.69% |
| Market cap | $356M |
| P/E | — |
| Revenue | $45M |
| Rev growth (YoY) | -6.1% |
| Net income | $-9741000000 |
| Net margin | -21820.3% |
| EPS (diluted) | $-0.34 |
| Piotroski F-ScoreUNVALIDATED | 1 |
| Altman Z-ScoreUNVALIDATED | 2.84 |
| Beneish M-ScoreUNVALIDATED | — |
| Next earnings | 03-18 → 03-28 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.